BOOK
Netter's Pediatrics E-Book
Todd Florin | Stephen Ludwig, MD | Paul L. Aronson | Heidi C. Werner
(2011)
Additional Information
Book Details
Abstract
Netter’s Pediatrics, edited by Drs. Todd Florin and Stephen Ludwig, is a rich visual aid with more than 500 images by Dr. Frank Netter and other artists working in his style that will help you diagnose and care for children with common clinical conditions. This is the first time that Netter’s drawings of pediatric illness are brought together in a single volume. The superb, accurate artwork accompanies up-to-date text contributed by physicians at the prestigious Children’s Hospital of Philadelphia. The book provides you with all the at-a-glance information you need for a quick overview of common issues from nutrition, allergy, infectious disease, and adolescent medicine, to cancer and heart disease. This user-friendly, clinical reference is also a great tool for patient and staff education.
- Efficiently review key details for each condition with 500 detailed, crystal-clear images provided by Frank H. Netter and others working in the Netter tradition.
- Apply dependable, concise, clinical advice from a team of physicians at Children’s Hospital of Philadelphia, one of the top children’s hospitals in the U.S.
- Get answers at a glance during pediatric rotations when studying for exams or preparing for consultations.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front cover | cover | ||
Marketing page | i | ||
Netter's Pediatrics | iii | ||
Copyright page | iv | ||
About the Editors | v | ||
About the Artists | vi | ||
Preface | vii | ||
Dedication | viii | ||
Acknowledgments | ix | ||
Editors | x | ||
Contributors | xii | ||
Table of Contents | xx | ||
I Care of the Acutely Ill Child | 1 | ||
1 Resuscitation | 2 | ||
Etiology and Pathogenesis | 2 | ||
Clinical Presentation | 2 | ||
Initial Assessment | 2 | ||
Primary Assessement | 2 | ||
Airway | 3 | ||
Breathing | 6 | ||
Circulation | 6 | ||
Disability | 9 | ||
Exposure | 9 | ||
Secondary Assessment | 10 | ||
Future Directions | 10 | ||
Suggested Readings | 10 | ||
2 Shock | 11 | ||
Etiology and Pathogenesis | 11 | ||
Compensated (Early) Shock | 11 | ||
Uncompensated (Late) Shock | 11 | ||
Classification of Shock | 11 | ||
Hypovolemic Shock | 11 | ||
Distributive Shock | 11 | ||
Cardiogenic Shock | 12 | ||
Neurogenic Shock | 12 | ||
Septic Shock | 12 | ||
Clinical Manifestations and Evaluation | 12 | ||
Management | 13 | ||
General Principles | 13 | ||
Circulatory Support | 14 | ||
Special Circumstances: Shock in Neonates | 15 | ||
Future Directions | 15 | ||
Suggested Readings | 16 | ||
3 Respiratory Distress | 17 | ||
Etiology and Pathogenesis | 17 | ||
Clinical Presentation | 17 | ||
Initial Assessment | 17 | ||
History | 17 | ||
Physical Examination | 17 | ||
Vital Signs | 17 | ||
Respiratory Examination | 17 | ||
Differential Diagnosis | 19 | ||
Evaluation and Management | 19 | ||
Algorithm | 19 | ||
Initial Management | 19 | ||
Diagnostic Studies | 21 | ||
Radiographs | 21 | ||
Blood Tests | 22 | ||
Suggested Readings | 23 | ||
4 Diabetic Ketoacidosis | 24 | ||
Etiology and Pathogenesis | 24 | ||
Clinical Presentation | 24 | ||
Differential Diagnosis | 24 | ||
Evaluation and Management | 26 | ||
Dehydration | 26 | ||
Electrolyte Loss | 26 | ||
Acidosis | 27 | ||
Hyperglycemia | 27 | ||
Monitoring | 27 | ||
Complications | 27 | ||
Resolution | 27 | ||
Future Directions | 28 | ||
Suggested Readings | 28 | ||
5 The Acute Abdomen | 29 | ||
Etiology and Pathogenesis | 29 | ||
Clinical Presentation | 29 | ||
Differential Diagnosis | 29 | ||
History | 29 | ||
Pain Character | 29 | ||
Associated Symptoms | 30 | ||
Pertinent Medical History | 31 | ||
Physical Examination | 31 | ||
Evaluation and Management | 32 | ||
Laboratory Testing | 32 | ||
Imaging Studies | 33 | ||
Management | 34 | ||
Future Directions | 34 | ||
Suggested Readings | 34 | ||
6 Drowning | 35 | ||
Etiology and Pathogenesis | 35 | ||
Clinical Presentation | 35 | ||
Evaluation and Management | 36 | ||
Prevention | 37 | ||
Future Directions | 38 | ||
Suggested Readings | 38 | ||
7 Burns | 39 | ||
Etiology and Pathogenesis | 39 | ||
Clinical Presentation | 39 | ||
Evaluation and Management | 41 | ||
Suggested Readings | 44 | ||
8 Injury and Trauma | 45 | ||
Etiology and Pathogenesis | 45 | ||
Evaluation and Management | 45 | ||
Primary Survey (see Chapter 1) | 45 | ||
Airway | 45 | ||
Breathing | 45 | ||
Circulation | 46 | ||
Disability | 47 | ||
Exposure and Environment | 47 | ||
Secondary Survey | 47 | ||
Head | 48 | ||
Neck and Spine | 50 | ||
Chest | 51 | ||
Abdomen | 52 | ||
Pelvis | 54 | ||
Extremities and Neurologic Status | 54 | ||
Radiation | 54 | ||
Prevention | 54 | ||
Suggested Readings | 54 | ||
9 Poisoning | 56 | ||
Etiology and Pathogenesis | 56 | ||
Tricyclic Antidepressants | 56 | ||
Antimalarials | 56 | ||
Calcium Channel Blockers and Beta-Adrenergic Blockers | 56 | ||
Camphor | 56 | ||
Salicylates | 56 | ||
Sulfonylureas | 56 | ||
Opioids | 56 | ||
Antidiarrheals | 57 | ||
Clinical Presentation | 57 | ||
Evaluation and Management | 57 | ||
Activated Charcoal | 59 | ||
Gastric Lavage | 59 | ||
Whole-Bowel Irrigation | 60 | ||
Dilution | 60 | ||
Ipecac | 60 | ||
Cathartics | 60 | ||
Future Directions | 61 | ||
Suggested Readings | 61 | ||
10 Neurologic Emergencies | 62 | ||
Status Epilepticus | 62 | ||
Etiology and Pathogenesis | 62 | ||
Clinical Presentation | 62 | ||
History | 62 | ||
Physical Examination | 62 | ||
Differential Diagnosis | 62 | ||
Evaluation and Management | 63 | ||
Altered Level of Consciousness | 63 | ||
Etiology and Pathogenesis | 64 | ||
Evaluation and Management | 64 | ||
Increased Intracranial Pressure | 65 | ||
Etiology and Pathogenesis | 65 | ||
Clinical Manifestations | 65 | ||
Evaluation and Management | 65 | ||
Suggested Readings | 66 | ||
11 Apparent Life-Threatening Event and Sudden Infant Death Syndrome | 67 | ||
Apparent Life-Threatening Event | 67 | ||
Etiology and Pathogenesis | 67 | ||
Clinical Presentation | 67 | ||
Evaluation and Management | 67 | ||
Home Apnea Monitoring | 68 | ||
Future Directions | 69 | ||
Sudden Infant Death Syndrome | 69 | ||
Etiology and Pathogenesis | 69 | ||
Clinical Presentation | 70 | ||
Evaluation and Management | 70 | ||
Prevention and Future Directions | 71 | ||
Suggested Readings | 71 | ||
Apparent Life-Threatening Event | 71 | ||
Sudden Infant Death Syndrome | 71 | ||
12 Child Abuse and Neglect | 72 | ||
Physical Abuse | 72 | ||
Clinical Presentation | 72 | ||
Evaluation and Management | 72 | ||
Sexual Abuse | 73 | ||
Clinical Presentation | 73 | ||
Evaluation and Management | 73 | ||
Physical Abandonment and Neglect | 77 | ||
Clinical Presentation | 78 | ||
Evaluation and Management | 78 | ||
Suggested Readings | 79 | ||
II Nutrition | 81 | ||
13 Nutritional Requirements and Growth | 82 | ||
Nutritional Requirements | 82 | ||
Fluids and Electrolytes | 82 | ||
Calories | 82 | ||
Macronutrients | 82 | ||
Protein | 82 | ||
Fat | 82 | ||
Carbohydrates | 82 | ||
Micronutrients | 83 | ||
Calcium | 83 | ||
Vitamin D | 83 | ||
Iron | 83 | ||
Other Micronutrients | 83 | ||
Counseling | 84 | ||
Infants | 84 | ||
Children | 84 | ||
Beverages | 84 | ||
Growth | 84 | ||
Types of Measurements | 85 | ||
Measurement Methods | 85 | ||
Use of Growth Curves | 85 | ||
Assessing a Child’s Growth | 85 | ||
Weight | 86 | ||
Height and Length | 86 | ||
Weight for Height and Body Mass Index | 87 | ||
Head Circumference | 87 | ||
Future Directions | 87 | ||
Suggested Readings | 87 | ||
14 Malnutrition | 88 | ||
Clinical Presentation | 88 | ||
Differential Diagnosis | 88 | ||
Physiologic Changes Accompanying Malnutrition | 88 | ||
Diagnostic Evaluations | 88 | ||
Management | 89 | ||
Management of Dehydration in Severely Malnourished Children | 91 | ||
Future Directions | 92 | ||
Suggested Readings | 92 | ||
15 Obesity | 93 | ||
Etiology and Pathogenesis | 93 | ||
Clinical Presentation | 93 | ||
Management | 93 | ||
Prevention | 93 | ||
Treatment Options | 93 | ||
Behavioral | 93 | ||
Pharmacologic | 94 | ||
Surgery | 95 | ||
Future Directions | 95 | ||
Suggested Readings | 96 | ||
16 Nutritional Deficiencies | 97 | ||
Deficiencies | 97 | ||
Iron | 97 | ||
Iodine | 97 | ||
Zinc | 97 | ||
Vitamin A | 97 | ||
Vitamin B | 98 | ||
Vitamin C | 100 | ||
Vitamin D | 100 | ||
Future Directions | 101 | ||
Suggested Readings | 101 | ||
17 Failure to Thrive | 102 | ||
Definition | 102 | ||
Etiology and Pathogenesis | 102 | ||
Nonorganic Factors | 102 | ||
Organic Factors | 102 | ||
Clinical Presentation | 102 | ||
Differential Diagnosis | 103 | ||
Evaluation and Management | 103 | ||
Evaluation | 103 | ||
Diet and Feeding | 103 | ||
Psychosocial Factors Contributing to Failure to Thrive | 103 | ||
Organic Causes of Failure to Thrive | 104 | ||
Associated Conditions | 105 | ||
Management | 105 | ||
Treatment of Underlying Cause | 105 | ||
Treatment of Feeding Difficulties | 105 | ||
Supplemental Feeds | 105 | ||
Hospitalization | 105 | ||
Social Services | 105 | ||
Future Directions | 106 | ||
Suggested Readings | 106 | ||
III Allergy and Immunology | 107 | ||
18 Anaphylaxis | 108 | ||
Etiology and Pathogenesis | 108 | ||
Clinical Presentation | 108 | ||
Differential Diagnosis | 108 | ||
Evaluation and Management | 109 | ||
Management | 109 | ||
Emergency Management | 110 | ||
Hospital Management | 111 | ||
Disposition | 112 | ||
Outpatient Management | 112 | ||
Future Directions | 112 | ||
Suggested Readings | 113 | ||
19 Atopic Dermatitis | 114 | ||
Etiology and Pathogenesis | 114 | ||
Clinical Presentation | 114 | ||
History | 114 | ||
Physical Examination | 114 | ||
Complications | 114 | ||
Staphylococcus aureus Superinfection | 114 | ||
Eczema Herpeticum | 115 | ||
Evaluation and Management | 115 | ||
Laboratory Testing | 115 | ||
Diagnosis | 116 | ||
Approach to Therapy | 116 | ||
Topical Calcineurin Inhibitors | 117 | ||
Additional Pharmacologic Therapies | 117 | ||
Nonpharmacologic Interventions | 117 | ||
Prevention of Atopic Dermatitis in Infants | 117 | ||
Treatment of Complications | 117 | ||
Treatment of Staphylococcus aureus Skin Colonization | 117 | ||
Future Directions | 118 | ||
Suggested Readings | 118 | ||
20 Urticaria and Angioedema | 119 | ||
Etiology and Pathogenesis | 119 | ||
Acute Urticaria | 119 | ||
Chronic Idiopathic Urticaria | 119 | ||
Physical Urticaria | 119 | ||
Angioedema | 120 | ||
Clinical Presentation | 120 | ||
History | 121 | ||
Physical Examination | 121 | ||
Evaluation and Management | 122 | ||
Laboratory Testing | 122 | ||
Management | 122 | ||
Future Directions | 123 | ||
Suggested Readings | 123 | ||
21 Approach to the Child with Primary Immunodeficiency | 124 | ||
Etiology and Pathogenesis | 124 | ||
Disorders of the Innate Immune System | 124 | ||
Phagocytes | 124 | ||
Natural Killer Cells | 124 | ||
Complement | 124 | ||
Toll-like Receptors | 124 | ||
Disorders of the Adaptive Immune System | 125 | ||
Humoral Immune System | 125 | ||
Cell-Mediated Immune System | 125 | ||
Other Defects of the Adaptive Immune System | 126 | ||
Clinical Presentation | 126 | ||
History | 126 | ||
Physical Exam | 126 | ||
Differential Diagnosis | 126 | ||
Evaluation and Management | 126 | ||
Laboratory Studies | 126 | ||
Radiographic Studies | 127 | ||
Management | 127 | ||
Future Directions | 128 | ||
Suggested Readings | 129 | ||
IV Bone and Joint Disorders | 131 | ||
22 Common Fractures | 132 | ||
Fracture Description | 132 | ||
Common Fracture Types in Children | 132 | ||
Physeal Fractures | 132 | ||
Salter-Harris Type I Fracture | 132 | ||
Salter-Harris Type II Fracture | 132 | ||
Salter-Harris Type III Fracture | 133 | ||
Salter-Harris Type IV Fracture | 133 | ||
Salter-Harris Type V Fracture | 133 | ||
Greenstick Fractures | 133 | ||
Torus Fractures | 133 | ||
Bowing Fractures | 134 | ||
Apophyseal Avulsion Fractures | 134 | ||
Fractures of the Upper Extremity | 134 | ||
Clavicle Fractures | 134 | ||
Fractures of the Humerus | 135 | ||
Elbow Fractures | 135 | ||
Anatomy of the Elbow | 135 | ||
Supracondylar Fractures | 135 | ||
Forearm Fractures | 136 | ||
Fractures of the Hand and Wrist | 136 | ||
Fractures of the Wrist | 136 | ||
Metacarpal Fractures | 136 | ||
Fractures of the Phalanges | 137 | ||
Fractures of the Pelvis and Lower Extremities | 137 | ||
Fractures of the Pelvis | 137 | ||
Fractures of the Femur | 138 | ||
Fractures of the Tibia and Fibula | 138 | ||
Toddler’s Fracture | 138 | ||
Fractures of the Ankle and Foot | 139 | ||
Distal Tibial and Fibular Fractures | 139 | ||
Fractures of the Foot | 140 | ||
Future Directions | 140 | ||
Suggested Readings | 140 | ||
23 Disorders of the Hip and Lower Extremity | 141 | ||
Congenital | 141 | ||
Clubfoot | 141 | ||
Developmental | 141 | ||
In-toeing | 141 | ||
Metatarsus Adductus | 141 | ||
Internal Tibial Torsion | 141 | ||
Femoral Anteversion | 141 | ||
Bowlegs | 142 | ||
Blount’s Disease and Adolescent Tibia Vara | 142 | ||
Rickets | 142 | ||
Developmental Dysplasia of the Hip | 142 | ||
Acquired | 144 | ||
Slipped Capital Femoral Epiphysis | 144 | ||
Legg-Calvé-Perthes Disease | 144 | ||
Transient Synovitis | 145 | ||
Osteoid Osteoma | 145 | ||
Future Directions | 146 | ||
Suggested Readings | 146 | ||
24 Disorders of the Neck and Spine | 147 | ||
Congenital Muscular Torticollis | 147 | ||
Scoliosis | 147 | ||
Kyphosis | 148 | ||
Spondylolysis and Spondylolisthesis | 148 | ||
Vertebral Compression Fractures | 149 | ||
Intervertebral Disk Herniation | 149 | ||
Future Directions | 150 | ||
Suggested Readings | 150 | ||
25 Sports Medicine | 151 | ||
Etiology and Pathogenesis | 151 | ||
Injuries by Body System | 151 | ||
Shoulder Injuries | 151 | ||
Acromioclavicular Separation | 151 | ||
Anterior Shoulder Dislocation | 151 | ||
Elbow Injuries | 151 | ||
Elbow Dislocation | 152 | ||
Elbow Overuse Injuries | 152 | ||
Hip Injuries | 153 | ||
Avulsion Fractures | 153 | ||
Femoral Neck Stress Fractures | 153 | ||
Knee Injuries | 153 | ||
Patellar Dislocation | 153 | ||
Osgood-Schlatter Disease | 154 | ||
Patellofemoral Pain Syndrome | 154 | ||
Osteochondritis Dissecans | 155 | ||
Soft Tissue Injuries | 155 | ||
Leg, Ankle, and Foot Injuries | 155 | ||
Shin Splints | 155 | ||
Ankle Sprains | 155 | ||
Sever Disease | 156 | ||
Future Directions | 156 | ||
Suggested Readings | 156 | ||
V Rheumatologic Disorders | 157 | ||
26 Chronic Arthritis | 158 | ||
Etiology and Pathogenesis | 158 | ||
Clinical Presentation | 158 | ||
Oligoarticular Juvenile Idiopathic Arthritis | 158 | ||
Polyarticular Juvenile Idiopathic Arthritis | 158 | ||
Systemic Juvenile Idiopathic Arthritis | 158 | ||
Psoriatic Arthritis | 160 | ||
Enthesitis-Related Arthritis | 160 | ||
Undifferentiated Arthritis | 160 | ||
Differential Diagnosis | 161 | ||
Evaluation and Management | 161 | ||
Laboratory Analysis | 161 | ||
Synovial Fluid Analysis | 162 | ||
Imaging | 162 | ||
Clinical Management | 162 | ||
Pharmacologic Interventions | 162 | ||
Surgical Management | 162 | ||
Physical and Occupational Therapy | 162 | ||
Future Directions | 162 | ||
Suggested Readings | 162 | ||
27 Juvenile Dermatomyositis | 163 | ||
Etiology and Pathogenesis | 163 | ||
Clinical Presentation | 163 | ||
Cutaneous Features | 163 | ||
Musculoskeletal Features | 163 | ||
Other Disease Manifestations | 164 | ||
Differential Diagnosis | 164 | ||
Evaluation and Management | 164 | ||
Future Directions | 165 | ||
Suggested Readings | 166 | ||
28 Vasculitis | 167 | ||
Etiology and Pathogenesis | 167 | ||
Classification | 167 | ||
Clinical Presentation | 167 | ||
Physical Examination | 167 | ||
Evaluation and Management | 168 | ||
Laboratory Evaluation | 168 | ||
Management | 168 | ||
Henoch Schönlein Purpura | 168 | ||
Kawasaki Disease | 170 | ||
Future Directions | 171 | ||
Suggested Readings | 172 | ||
29 Systemic Lupus Erythematosus | 173 | ||
Etiology and Pathogenesis | 173 | ||
Clinical Presentation | 173 | ||
Skin and Mucus Membrane Manifestations | 173 | ||
Musculoskeletal Manifestations | 173 | ||
Renal Manifestations | 173 | ||
Neuropsychiatric Manifestations | 174 | ||
Hematologic Manifestations | 174 | ||
Cardiopulmonary Manifestations | 174 | ||
Differential Diagnosis | 174 | ||
Morbidity and Mortality | 175 | ||
Evaluation and Management | 175 | ||
Management | 176 | ||
Mild Disease | 177 | ||
Moderate to Severe Disease | 177 | ||
Future Directions | 177 | ||
Suggested Readings | 177 | ||
30 Granulomatous Disease | 178 | ||
Sarcoidosis | 178 | ||
Etiology and Pathogenesis | 178 | ||
Clinical Presentation | 178 | ||
Lymphoreticular System Manifestations | 178 | ||
Pulmonary Manifestations | 178 | ||
Ocular Manifestations | 178 | ||
Skin Manifestations | 178 | ||
Musculoskeletal Manifestations | 178 | ||
Central Nervous System Manifestations | 178 | ||
Other Manifestations | 179 | ||
Differential Diagnosis | 179 | ||
Evaluation and Management | 179 | ||
Blood and Urine Studies | 179 | ||
Imaging | 180 | ||
Histology | 181 | ||
Pulmonary Function Testing | 181 | ||
Ophthalmologic Evaluation | 181 | ||
Management | 181 | ||
Wegener Granulomatosis | 181 | ||
Etiology and Pathogenesis | 181 | ||
Clinical Presentation | 181 | ||
Pulmonary Manifestations | 181 | ||
Renal Manifestations | 181 | ||
Ear, Nose, and Throat Manifestations | 181 | ||
Ocular Manifestations | 181 | ||
Musculoskeletal Manifestations | 181 | ||
Skin Manifestations | 181 | ||
CNS Manifestations | 181 | ||
Other Manifestations | 181 | ||
Differential Diagnosis | 182 | ||
VI Disorders of the Head, Neck, and Upper Airway | 185 | ||
31 Otitis | 186 | ||
Otitis Externa | 186 | ||
Etiology and Pathogenesis | 186 | ||
Clinical Presentation | 186 | ||
Evaluation and Management | 186 | ||
Future Directions | 187 | ||
Otitis Media | 188 | ||
Etiology and Pathogenesis | 188 | ||
Clinical Presentation | 188 | ||
Acute Otitis Media | 188 | ||
Otitis Media with Effusion | 189 | ||
Evaluation and Management | 189 | ||
Acute Otitis Media Treatment | 190 | ||
Otitis Media with Effusion Treatment | 190 | ||
Future Directions | 191 | ||
Suggested Readings | 191 | ||
Otitis Externa | 191 | ||
Otitis Media | 191 | ||
32 Disorders of the Eye | 192 | ||
Abnormal Red Light Reflex | 192 | ||
Cataracts | 192 | ||
Retinoblastoma | 192 | ||
Disorders of Eye Movement | 192 | ||
Strabismus | 192 | ||
Amblyopia | 192 | ||
Red Eye | 193 | ||
Viral Conjunctivitis | 193 | ||
Bacterial Conjunctivitis | 193 | ||
Allergic Conjunctivitis | 194 | ||
Chemical Conjunctivitis | 194 | ||
Uveitis | 194 | ||
Disorders of Adnexal Structures | 194 | ||
Nasolacrimal Duct Obstruction | 194 | ||
Hordeolum and Chalazion | 194 | ||
Preseptal (Periorbital) Cellulitis | 194 | ||
Orbital Cellulitis | 194 | ||
Ocular Trauma | 195 | ||
Corneal Abrasion | 195 | ||
Hyphema | 195 | ||
Retinal Hemorrhage | 196 | ||
Subconjunctival Hemorrhage | 196 | ||
Future Directions | 196 | ||
Suggested Readings | 196 | ||
33 Sinusitis | 198 | ||
Etiology and Pathogenesis | 198 | ||
Clinical Presentation | 198 | ||
Evaluation and Management | 198 | ||
Evaluation | 198 | ||
Management | 199 | ||
Antimicrobial Therapy | 199 | ||
Adjuvant and Surgical Therapy | 200 | ||
Rhinitis without Sinusitis | 200 | ||
Complications | 201 | ||
Future Directions | 201 | ||
Suggested Readings | 201 | ||
34 Dentition and Common Oral Lesions | 202 | ||
Dentition | 202 | ||
Normal Tooth Anatomy | 202 | ||
Dental Trauma | 202 | ||
Dental Infections | 202 | ||
Caries | 202 | ||
Periodontal Infections | 204 | ||
Lesions of the Oral Soft Tissues | 204 | ||
Anatomic Lesions of the Oral Cavity | 204 | ||
Ankyloglossia | 204 | ||
Geographic Tongue | 204 | ||
Common Soft Tissue Lesions of the Oral Cavity | 204 | ||
Mucocele | 204 | ||
Ranula | 204 | ||
Traumatic Ulcers | 204 | ||
Aphthous Ulcers | 205 | ||
Soft Tissue Infections of the Oral Cavity | 205 | ||
Candidiasis | 205 | ||
Primary Herpetic Gingivostomatitis | 205 | ||
Enterovirus Infections | 206 | ||
Future Directions | 206 | ||
Suggested Readings | 206 | ||
35 Pharyngitis | 207 | ||
Etiology and Pathogenesis | 207 | ||
Clinical Presentation | 207 | ||
Evaluation and Management | 207 | ||
Future Directions | 211 | ||
Suggested Readings | 211 | ||
36 Stridor | 212 | ||
Etiology and Pathogenesis | 212 | ||
VII Disorders of the Respiratory System and Lower Airway | 217 | ||
37 Bronchiolitis and Wheezing | 218 | ||
Etiology and Pathogenesis | 218 | ||
Bronchiolitis | 218 | ||
Asthma | 218 | ||
Other Causes of Wheezing | 220 | ||
Clinical Presentation | 220 | ||
Evaluation and Management | 222 | ||
Future Directions | 222 | ||
Suggested Readings | 223 | ||
38 Asthma | 224 | ||
Etiology and Pathogenesis | 224 | ||
Clinical Presentation | 224 | ||
Differential Diagnosis | 225 | ||
Evaluation | 226 | ||
Chronic Disease | 226 | ||
Acute Exacerbation | 226 | ||
Management | 229 | ||
Chronic Disease | 229 | ||
Acute Exacerbation | 229 | ||
Future Directions | 230 | ||
Conclusion | 231 | ||
Suggested Readings | 231 | ||
39 Congenital Anomalies of the Lung | 232 | ||
Congenital Anomalies of the Airway | 232 | ||
Etiology and Pathogenesis | 232 | ||
Clinical Presentation | 232 | ||
Evaluation and Management | 233 | ||
Congenital Anomalies of Lung Parenchyma | 233 | ||
Etiology and Pathogenesis | 233 | ||
Clinical Presentation | 234 | ||
Evaluation and Management | 235 | ||
Antenatal | 235 | ||
Postnatal | 235 | ||
Pulmonary Vascular Malformations | 236 | ||
Etiology and Pathogenesis | 236 | ||
Clinical Presentation | 237 | ||
Evaluation and Management | 237 | ||
Future Directions | 237 | ||
Suggested Readings | 237 | ||
40 Pleural Effusions and Pneumothorax | 239 | ||
Pleural Effusions | 239 | ||
Etiology and Pathogenesis | 239 | ||
Clinical Presentation | 239 | ||
Evaluation and Management | 240 | ||
Pneumothorax | 242 | ||
Etiology and Pathogenesis | 242 | ||
Primary Spontaneous Pneumothorax | 242 | ||
Secondary Spontaneous Pneumothorax | 243 | ||
Clinical Presentation | 243 | ||
Evaluation and Management | 244 | ||
Future Directions | 244 | ||
Suggested Readings | 244 | ||
41 Cystic Fibrosis | 246 | ||
Etiology and Pathogenesis | 246 | ||
Clinical Presentation | 246 | ||
Diagnosis | 248 | ||
Management | 248 | ||
Future Directions | 249 | ||
Suggested Readings | 249 | ||
VIII Disorders of the Cardiovascular System | 251 | ||
42 Development of the Cardiovascular System | 252 | ||
Embryologic Development | 252 | ||
Heart Tube Formation | 252 | ||
Cardiac Looping | 252 | ||
Endocardial Cushion Development and Atrial Septation | 252 | ||
Ventricular Septation | 253 | ||
Development of Major Aortic and Pulmonary Outflow Tracts | 254 | ||
Development of the Great Arteries | 254 | ||
Development of Major Systemic and Pulmonary Veins | 254 | ||
Development of Cardiac Conduction System and Coronary Vessels | 256 | ||
Fetal Circulation | 256 | ||
Postnatal Transitions And Neonatal Circulation | 257 | ||
Future Directions | 258 | ||
Suggested Readings | 258 | ||
43 Acyanotic Congenital Heart Disease | 259 | ||
Shunt Lesions | 259 | ||
Atrial Septal Defect | 259 | ||
Ventricular Septal Defect | 259 | ||
Common Atrioventricular Canal | 260 | ||
Patent Ductus Arteriosus | 261 | ||
Nonshunt Lesions | 261 | ||
Aortic Valve Disease | 261 | ||
Coarctation of the Aorta | 263 | ||
Pulmonary Valve Disease | 266 | ||
Mitral Valve Disease | 267 | ||
Vascular Ring | 267 | ||
Future Directions | 268 | ||
Suggested Readings | 268 | ||
44 Cyanotic Congenital Heart Disease | 269 | ||
Pathophysiology Of Cyanosis | 269 | ||
Clinical Presentation And Evaluation | 269 | ||
Transposition of the Great Arteries | 270 | ||
Tetralogy of Fallot | 271 | ||
Double Outlet Right Ventricle with Pulmonic Stenosis | 272 | ||
Tricuspid Atresia | 272 | ||
Critical Pulmonic Stenosis | 273 | ||
Pulmonary Atresia | 273 | ||
Ebstein’s Anomaly of the Tricuspid Valve | 273 | ||
Total Anomalous Pulmonary Venous Connection | 275 | ||
Truncus Arteriosus Communis | 275 | ||
Future Directions | 275 | ||
Suggested Readings | 277 | ||
45 Arrhythmias | 278 | ||
Sinus Arrhythmias and Premature Impulses | 278 | ||
Sinus Bradycardia | 278 | ||
Sinus Arrhythmia | 278 | ||
Sinus Pauses | 278 | ||
Premature Atrial Contractions | 278 | ||
Premature Ventricular Contractions | 278 | ||
Bradyarrhythmias | 278 | ||
Sinus Node Dysfunction | 278 | ||
Atrioventricular Conduction Abnormalities | 278 | ||
First-Degree Atrioventricular Block | 278 | ||
Second-Degree Atrioventricular Block | 279 | ||
Third-Degree Atrioventricular Block or Complete Atrioventricular Block | 279 | ||
Congenital Complete Heart Block | 279 | ||
Acquired Complete Heart Block | 280 | ||
Tachyarrhythmias | 281 | ||
Supraventricular Tachycardias | 281 | ||
Reentry Tachycardia with an Accessory Pathway | 281 | ||
Reentry Tachycardia without an Accessory Pathway | 281 | ||
Automatic Tachycardias | 282 | ||
Ventricular Tachycardia | 283 | ||
Long Qt Syndromes And Sudden Death | 283 | ||
future directions | 283 | ||
Suggested Readings | 284 | ||
46 Heart Failure | 285 | ||
Etiology And Presentation | 285 | ||
Evaluation and Management | 285 | ||
Case Example | 287 | ||
Future Directions | 288 | ||
Suggested Readings | 288 | ||
47 Hypertension | 289 | ||
Etiology And Pathogenesis | 289 | ||
Definitions | 289 | ||
Physiology | 289 | ||
Clinical Presentation | 289 | ||
Evaluation | 289 | ||
Measurement of Blood Pressure | 289 | ||
Cuff Size and Location | 290 | ||
Diagnostic Approach | 290 | ||
Management | 292 | ||
Future Directions | 293 | ||
Suggested Readings | 293 | ||
48 Syncope | 294 | ||
Etiology And Pathogenesis | 294 | ||
Neurally Mediated Syncope | 294 | ||
Vasovagal Syncope | 294 | ||
Situational Syncope | 294 | ||
Orthostatic Syncope | 294 | ||
Postural Orthostatic Tachycardia Syndrome | 294 | ||
Dysautonomia | 294 | ||
Breath-Holding Spells | 294 | ||
Cardiac Syncope | 295 | ||
Arrhythmias | 295 | ||
Long QT Syndrome | 295 | ||
Preexcitation Syndromes | 295 | ||
Short QT Syndrome | 295 | ||
Brugada Syndrome | 295 | ||
Catecholaminergic Polymorphic Ventricular Tachycardia | 296 | ||
Bradycardia | 296 | ||
Structural Heart Disease | 296 | ||
Hypertrophic Cardiomyopathy | 296 | ||
Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia | 297 | ||
Dilated Cardiomyopathy | 297 | ||
Aortic Stenosis | 297 | ||
Abnormal Origin of the Coronary Arteries | 297 | ||
Pulmonary Hypertension | 297 | ||
Acute Myocarditis | 297 | ||
Congestive Heart Failure | 297 | ||
Metabolic Syncope | 297 | ||
Syncope-like Events | 297 | ||
Evaluation And Diagnostic Approach | 298 | ||
Management: Indications For Referral And Admission | 298 | ||
Future Directions | 298 | ||
Suggested Readings | 299 | ||
49 Acute Rheumatic Fever and Rheumatic Heart Disease | 300 | ||
Etiology And Pathogenesis | 300 | ||
Clinical Presentation | 300 | ||
Diagnostic Evaluation | 300 | ||
Laboratory Studies | 300 | ||
Cardiac Evaluation | 302 | ||
Chest Radiography | 302 | ||
Electrocardiography | 302 | ||
Two-Dimensional Echocardiography and Color Doppler | 302 | ||
Cardiac Magnetic Resonance Imaging | 302 | ||
Cardiac Catheterization | 302 | ||
Management And Therapy | 302 | ||
Acute Rheumatic Fever and Rheumatic Carditis | 302 | ||
Chronic Rheumatic Heart Disease | 304 | ||
Future Directions | 305 | ||
Suggested Readings | 306 | ||
IX Hematologic Disorders | 307 | ||
50 Disorders of Red Blood Cells | 308 | ||
Etiology and Pathogenesis | 308 | ||
Congenital Red Blood Cell Disorders | 308 | ||
Membrane Defects | 308 | ||
Thalassemias | 308 | ||
Hemoglobinopathies | 308 | ||
Enzyme Deficiencies | 308 | ||
Diamond-Blackfan Anemia | 309 | ||
Congenital Bone Marrow Failure Syndromes | 309 | ||
Acquired Red Blood Cell Disorders | 309 | ||
Mechanical Red Blood Cell Destruction | 309 | ||
Autoimmune Hemolytic Anemia | 309 | ||
Anemia of Chronic Disease | 309 | ||
Nutritional Deficiencies | 310 | ||
Transient Erythroblastopenia of Childhood | 310 | ||
Transient Red Blood Cell Aplasia from Parvovirus B19 | 310 | ||
Clinical Presentation and Differential Diagnosis | 310 | ||
Diagnostic Approach | 310 | ||
Management and Therapy | 312 | ||
Congenital Disorders | 312 | ||
Acquired Disorders | 312 | ||
Future Directions | 313 | ||
Suggested Readings | 313 | ||
51 Disorders of White Blood Cells | 314 | ||
Etiology and Pathogenesis | 314 | ||
Clinical Presentation and Differential Diagnosis | 314 | ||
Congenital Disorders of Neutrophils | 314 | ||
Neutrophil Function Defects | 314 | ||
Acquired Disorders of Neutrophils | 314 | ||
Infection-Associated Neutropenia | 314 | ||
Autoimmune Neutropenia | 314 | ||
Isoimmune or Alloimmune Neonatal Neutropenia | 315 | ||
Drug-Induced Neutropenia | 315 | ||
Other Causes of Acquired Neutropenia | 315 | ||
Leukocytosis | 315 | ||
Neutrophilia | 316 | ||
Monocytosis | 316 | ||
Basophilia | 316 | ||
Eosinophilia | 316 | ||
Evaluation and Management | 318 | ||
Future Directions | 320 | ||
Suggested Readings | 320 | ||
52 Platelet Disorders | 321 | ||
Etiology and Pathogenesis | 321 | ||
Congenital Platelet Disorders | 321 | ||
Glanzmann’s Thrombasthenia | 321 | ||
Bernard-Soulier Syndrome | 321 | ||
Storage Pool Defects | 321 | ||
Thrombocytopenia Absent Radii | 321 | ||
Congenital Amegakaryocytic Thrombocytopenia | 321 | ||
Wiskott-Aldrich | 321 | ||
Macrothrombocytopenia Disorders | 322 | ||
Essential Thrombocytosis | 322 | ||
Acquired Platelet Disorders | 322 | ||
Immune Thrombocytopenia | 323 | ||
Neonatal Alloimmune Thrombocytopenia | 323 | ||
Thrombotic Thrombocytopenic Purpura | 323 | ||
Heparin-Induced Thrombocytopenia | 323 | ||
Clinical Presentation And Differential Diagnosis | 323 | ||
Diagnostic Approach | 323 | ||
Management and Therapy | 324 | ||
Future Directions | 325 | ||
Suggested Readings | 325 | ||
53 Sickle Cell Disease | 326 | ||
Etiology and Pathogenesis | 326 | ||
Clinical Presentation | 326 | ||
Diagnostic Approach | 326 | ||
Management and Therapy | 326 | ||
Acute Complications | 326 | ||
Fever | 326 | ||
Vaso-occlusive Episodes | 326 | ||
Acute Chest Syndrome | 327 | ||
Splenic Sequestration | 328 | ||
Transient Red Blood Cell Aplasia | 328 | ||
Acute Stroke | 329 | ||
Priapism | 329 | ||
Routine Health Maintenance | 329 | ||
Immunizations | 329 | ||
Penicillin Prophylaxis | 329 | ||
Folic Acid | 329 | ||
Nutrition and Growth | 329 | ||
Stroke Screening | 329 | ||
Eye Examinations | 329 | ||
Chronic Issues | 329 | ||
Transfusion and Chelation Therapy | 329 | ||
Hydroxyurea | 330 | ||
Avascular Necrosis | 330 | ||
Future Directions | 330 | ||
Suggested Readings | 330 | ||
54 Disorders of Thrombosis and Hemostasis | 331 | ||
Epidemiology | 331 | ||
X Neoplastic Disorders | 337 | ||
55 Leukemia | 338 | ||
Etiology And Pathogenesis | 338 | ||
Genetics | 338 | ||
Clinical Presentation | 340 | ||
Evaluation | 340 | ||
Classification | 342 | ||
Management And Prognosis | 344 | ||
Acute Lymphoblastic Leukemia | 344 | ||
Acute Myelogenous Leukemia | 344 | ||
Chronic Myelogenous Leukemia | 344 | ||
Relapse | 344 | ||
Future Directions | 344 | ||
Suggested Readings | 344 | ||
56 Lymphomas | 346 | ||
Hodgkin’s Lymphoma | 346 | ||
Etiology and Pathogenesis | 346 | ||
Clinical Presentation | 346 | ||
Evaluation and Staging | 346 | ||
Management | 346 | ||
Future Directions | 347 | ||
Non-Hodgkin’s Lymphoma | 348 | ||
Etiology and Pathogenesis | 348 | ||
Clinical Presentation | 348 | ||
Evaluation and Staging | 349 | ||
Management | 349 | ||
Future Directions | 350 | ||
Suggested Readings | 350 | ||
57 Brain Tumors | 351 | ||
Etiology And Pathogenesis | 351 | ||
Clinical Presentation | 351 | ||
Differential Diagnosis | 351 | ||
Evaluation And Management | 351 | ||
Future Directions | 354 | ||
Suggested Readings | 354 | ||
58 Neuroblastoma | 355 | ||
Etiology and Pathogenesis | 355 | ||
Clinical Presentation | 355 | ||
Differential Diagnosis | 356 | ||
Evaluation | 356 | ||
Staging and Management | 356 | ||
Staging | 356 | ||
Surgery | 358 | ||
Chemotherapy | 358 | ||
Radiation Therapy | 358 | ||
Treatment of Paraneoplastic Syndromes | 358 | ||
Future Directions | 358 | ||
Suggested Readings | 359 | ||
59 Renal Neoplasms | 360 | ||
Etiology and Pathogenesis | 360 | ||
Wilms’ Tumor | 360 | ||
Rare Renal Tumors | 360 | ||
Clinical Presentation | 361 | ||
Wilms’ Tumor | 361 | ||
Rare Renal Tumors | 361 | ||
Clear Cell Sarcoma of the Kidney | 361 | ||
Rhabdoid Tumor of the Kidney | 361 | ||
Renal Cell Carcinoma | 361 | ||
Congenital Mesoblastic Nephroma | 361 | ||
Evaluation and Management | 362 | ||
Tumor-Specific Evaluations and Management | 362 | ||
Wilms’ Tumor | 362 | ||
Rare Renal Tumors | 364 | ||
Clear Cell Sarcoma of the Kidney | 364 | ||
Rhabdoid Tumor of the Kidney | 364 | ||
Renal Cell Carcinoma | 364 | ||
Congenital Mesoblastic Nephroma | 364 | ||
Follow-Up | 364 | ||
Future Directions | 364 | ||
Suggested Reading | 365 | ||
60 Bone Neoplasms | 366 | ||
Bone Tumors | 366 | ||
Osteosarcoma | 366 | ||
Epidemiology and Pathogenesis | 366 | ||
Clinical Presentation | 366 | ||
Evaluation | 366 | ||
Management | 366 | ||
Prognosis | 367 | ||
Ewing’s Sarcoma Family of Tumors | 367 | ||
Epidemiology | 367 | ||
Clinical Presentation | 368 | ||
Evaluation | 368 | ||
Management | 369 | ||
Prognosis | 369 | ||
Future Directions | 369 | ||
Suggested Readings | 369 | ||
XI Disorders of the Renal and Urologic Systems | 371 | ||
61 Hematuria and Proteinuria | 372 | ||
Hematuria | 372 | ||
Etiology and Pathogenesis | 372 | ||
Hypercalciuria and Urolithiasis | 372 | ||
Medications | 372 | ||
Glomerulonephritis | 372 | ||
Trauma | 372 | ||
Malignancy | 372 | ||
Hematologic Causes | 373 | ||
Alport Syndrome | 373 | ||
Benign Familial Hematuria | 373 | ||
Loin Pain-Hematuria Syndrome | 373 | ||
Urethrorrhagia | 373 | ||
Clinical Presentation | 374 | ||
History | 374 | ||
Physical Examination | 374 | ||
Evaluation and Management | 374 | ||
Diagnostic Modalities | 376 | ||
Treatment of Hematuria | 376 | ||
Proteinuria | 376 | ||
Etiology and Pathogenesis | 376 | ||
Benign Conditions | 376 | ||
Transient Proteinuria | 376 | ||
Orthostatic (Postural) Proteinuria | 376 | ||
Persistent Asymptomatic Isolated Proteinuria | 377 | ||
Pathologic Conditions | 377 | ||
Glomerulonephritis | 377 | ||
Nephrotic Syndrome | 377 | ||
Tubular Diseases | 377 | ||
Clinical Presentation and Detection | 377 | ||
Phase I Workup | 377 | ||
Qualitative Protein Detection | 377 | ||
Quantitative Protein Detection | 378 | ||
Evaluation and Management | 378 | ||
Phase II Workup | 378 | ||
Phase III Workup | 378 | ||
Future Directions | 378 | ||
Suggested Readings | 379 | ||
62 Glomerulonephritis | 380 | ||
Etiology and Pathogenesis | 380 | ||
Differential Diagnosis | 380 | ||
Acute Postinfectious Glomerulonephritis | 380 | ||
IgA Nephropathy | 380 | ||
Henoch-Schönlein Purpura Nephritis | 380 | ||
Rapidly Progressive Glomerulonephritis | 381 | ||
Membranoproliferative Glomerulonephritis | 381 | ||
Antineutrophilic Cytoplasmic Antibody–Positive Vasculitis/Pauci-Immune Glomerulonephritis | 381 | ||
Clinical Presentation | 381 | ||
Evaluation | 381 | ||
Recent Illnesses or Exposures | 382 | ||
Other Symptoms and Review of Systems | 383 | ||
Family History | 383 | ||
Physical Examination | 383 | ||
Intravascular Volume Status | 383 | ||
Other Physical Examination Findings | 383 | ||
Laboratory Evaluation | 383 | ||
Imaging | 383 | ||
Biopsy | 383 | ||
Management | 384 | ||
Therapies Targeting the Underlying Glomerulonephritis | 384 | ||
Future Directions | 384 | ||
Suggested Readings | 384 | ||
63 Nephrotic Syndrome | 385 | ||
Etiology and Pathogenesis | 385 | ||
Clinical Presentation | 385 | ||
Demographic Factors | 385 | ||
Edema | 385 | ||
Blood Pressure and Volume Status | 385 | ||
Urine | 386 | ||
Laboratory Findings | 387 | ||
Complications | 388 | ||
Evaluation and Management | 389 | ||
Supportive Therapy | 389 | ||
Glucocorticoids | 389 | ||
Other | 389 | ||
Suggested Readings | 389 | ||
64 Hemolytic-Uremic Syndromes | 390 | ||
Etiology and Pathogenesis | 390 | ||
Shiga Toxin–Associated Hemolytic-Uremic Syndrome | 390 | ||
Pneumococcal Hemolytic-Uremic Syndrome | 392 | ||
Genetic Forms of Hemolytic-Uremic Syndrome | 392 | ||
Thrombotic Thrombocytopenic Purpura | 394 | ||
Secondary Hemolytic-Uremic Syndrome | 394 | ||
Common Renal Pathology | 394 | ||
Clinical Presentation | 395 | ||
Hematologic Features | 395 | ||
Renal Features | 395 | ||
Extrarenal Features | 395 | ||
Differential Diagnosis | 396 | ||
Management | 396 | ||
Suggested Readings | 396 | ||
65 Acute and Chronic Renal Failure | 397 | ||
Acute Renal Failure | 397 | ||
Etiology and Pathogenesis | 397 | ||
Prerenal | 397 | ||
Renal | 397 | ||
Postrenal | 397 | ||
Clinical Presentation | 397 | ||
Evaluation and Diagnosis | 398 | ||
Serum Creatinine Concentration, Acute Kidney Injury Biomarkers, and Classification of Acute Kidney Injury | 398 | ||
Urinalysis | 398 | ||
Urine Sodium Excretion | 398 | ||
Fractional Excretion of Sodium | 399 | ||
Urine Osmolality | 399 | ||
Urine Volume | 399 | ||
Serologic and Biochemical Abnormalities | 399 | ||
Complete Blood Count | 399 | ||
Renal Imaging | 399 | ||
Renal Biopsy | 399 | ||
Prevention and Management | 399 | ||
Hyperphosphatemia and Hypocalcemia | 400 | ||
Hypertension | 400 | ||
Nutrition | 400 | ||
Renal Replacement Therapy | 400 | ||
Future Directions | 400 | ||
Chronic Kidney Disease | 400 | ||
Etiology and Pathogenesis | 401 | ||
Clinical Presentation | 402 | ||
Complications | 402 | ||
Evaluation | 403 | ||
History | 403 | ||
Physical Examination | 403 | ||
Laboratory Testing | 403 | ||
Urinalysis | 404 | ||
Renal Ultrasonography | 404 | ||
Kidney Biopsy | 405 | ||
Management | 405 | ||
Slowing Progression | 405 | ||
Management of Complications | 405 | ||
Renal Replacement Therapy | 406 | ||
Future Directions | 407 | ||
Suggested Readings | 407 | ||
66 Congenital Anomalies of the Kidney and Urologic System | 408 | ||
Polycystic Kidney Disease | 408 | ||
Autosomal Recessive Polycystic Kidney Disease | 408 | ||
Autosomal Dominant Polycystic Kidney Disease | 408 | ||
Horseshoe Kidney | 410 | ||
Urologic Malformations | 411 | ||
Double Ureter | 411 | ||
Ureteropelvic Junction Obstruction | 412 | ||
Posterior Urethral Valves | 412 | ||
Suggested Readings | 413 | ||
XII Disorders of the Endocrine System | 415 | ||
67 Puberty | 416 | ||
Etiology And Pathogenesis | 416 | ||
Hormonal Changes of Puberty | 416 | ||
Normal Pubertal Timing | 416 | ||
Clinical Presentation | 416 | ||
Differential Diagnosis | 417 | ||
Premature Sex Hormone Effects | 417 | ||
Delayed Puberty (Box 67-2) | 418 | ||
Evaluation And Management | 421 | ||
Precocious Puberty | 421 | ||
Delayed Puberty | 421 | ||
Suggested Readings | 421 | ||
68 Thyroid Disease | 422 | ||
Thyroid Hormone Production | 422 | ||
Congenital Hypothyroidism | 422 | ||
Etiology and Pathogenesis | 422 | ||
Clinical Presentation | 422 | ||
Evaluation (Figure 68-3) | 422 | ||
Treatment | 423 | ||
Congenital Hyperthyroidism | 423 | ||
Acquired Hypothyroidism | 424 | ||
Etiology and Pathogenesis | 424 | ||
Clinical Presentation (Figure 68-4) | 424 | ||
Evaluation | 425 | ||
Treatment | 425 | ||
Acquired Hyperthyroidism | 426 | ||
Etiology and Pathogenesis (Box 68-1) | 426 | ||
Clinical Presentation (see Figure 68-4) | 426 | ||
Evaluation | 427 | ||
Treatment | 427 | ||
Future Directions | 428 | ||
Suggested Readings | 428 | ||
69 Disorders of Calcium and Bone Metabolism | 429 | ||
Regulation of Serum Calcium and Phosphorus | 429 | ||
Dynamics of Bone Homeostasis | 430 | ||
Osteomalacia and Rickets | 430 | ||
Nutritional Rickets | 430 | ||
Hypophosphatemic Rickets | 431 | ||
X-Linked Hypophosphatemic Rickets | 431 | ||
Autosomal Hypophosphatemic Rickets | 432 | ||
Hereditary Hypophosphatemic Rickets with Hypercalciuria | 432 | ||
Fanconi Syndrome | 434 | ||
Future Directions | 434 | ||
Suggested Readings | 435 | ||
70 Disorders of the Adrenal Gland | 436 | ||
Adrenal Gland Physiology | 436 | ||
Functions of Adrenal Hormones | 436 | ||
Adrenal Insufficiency | 436 | ||
Etiology and Pathogenesis | 436 | ||
Primary Adrenal Insufficiency | 436 | ||
Secondary Adrenal Insufficiency | 436 | ||
Iatrogenic Adrenal Insufficiency | 436 | ||
Clinical Presentation | 437 | ||
Evaluation and Management | 438 | ||
Laboratory Studies | 438 | ||
Treatment and Prognosis | 438 | ||
Cushing’s Syndrome | 439 | ||
Etiology and Pathogenesis | 439 | ||
Clinical Presentation | 439 | ||
Evaluation and Management | 439 | ||
Congenital Adrenal Hyperplasia | 440 | ||
Etiology and Pathogenesis | 440 | ||
Clinical Presentation | 440 | ||
Differential Diagnosis | 440 | ||
Evaluation and Management | 440 | ||
Future Directions | 441 | ||
Suggested Readings | 441 | ||
71 Diabetes Mellitus | 442 | ||
Etiology and Pathogenesis | 442 | ||
Type 1 Diabetes Mellitus | 442 | ||
Type 2 Diabetes Mellitus | 442 | ||
Clinical Presentation | 443 | ||
Type 2 Diabetes | 443 | ||
Evaluation and Management | 443 | ||
Initial Evaluation | 443 | ||
Well-Appearing Children | 443 | ||
Ill Children | 445 | ||
Post–Diabetic Ketoacidosis and Home Management | 445 | ||
Type 1 Diabetes | 445 | ||
Type 2 Diabetes Mellitus | 448 | ||
Complications and Comorbidities | 448 | ||
Future Directions | 449 | ||
Suggested Readings | 449 | ||
72 Hypoglycemia | 450 | ||
Etiology and Pathogenesis | 450 | ||
Clinical Presentation | 450 | ||
Differential Diagnosis | 450 | ||
Hypoglycemia Secondary to Excessive and Inappropriate Insulin | 450 | ||
Infant of a Diabetic Mother | 450 | ||
Prolonged Neonatal Hypoglycemia | 450 | ||
Permanent Hypoglycemia (Congenital Hyperinsulinism) | 451 | ||
Insulinoma | 451 | ||
Other Causes of Hyperinsulinism | 452 | ||
Factitious Hyperinsulinism | 452 | ||
Beckwith-Wiedemann Syndrome | 452 | ||
Congenital Disorders of Glycosylation | 453 | ||
Hypoglycemia Caused by Nonhyperinsulinemic States | 453 | ||
Disorders of Gluconeogenesis | 453 | ||
Disorders of Glycogen Storage | 453 | ||
Disorders of Fatty Acid Oxidation | 453 | ||
Pituitary Hormone Deficiency | 453 | ||
Adrenal Insufficiency (Addison’s Disease) | 454 | ||
Medication-Induced Hypoglycemia | 454 | ||
Postprandial Hypoglycemia (Dumping Syndrome) | 454 | ||
Ketotic Hypoglycemia | 454 | ||
Evaluation and Management | 454 | ||
Treatment of Hyperinsulinism | 454 | ||
Gluconeogenesis, Glycogenolysis, and Fat Oxidation | 456 | ||
Specific Hormonal Replacement | 456 | ||
Future Directions | 456 | ||
Suggested Readings | 456 | ||
73 Disorders of Growth | 457 | ||
Etiology and Pathogenesis | 457 | ||
Normal Growth Patterns | 457 | ||
Longitudinal Growth and Mediating Factors | 457 | ||
Abnormal Growth | 457 | ||
Clinical Presentation | 457 | ||
Familial Short Stature | 458 | ||
Constitutional Delay of Growth and Puberty | 459 | ||
Idiopathic Short Stature | 461 | ||
Intrauterine Growth Retardation and Small for Gestational Age | 461 | ||
Osteochondrodysplasias | 461 | ||
Turner Syndrome (See Chapter 118, Figure 118-1) | 461 | ||
Abnormalities of the Growth Hormone–Insulinlike Growth Factor Axis | 462 | ||
Poor Nutrition | 462 | ||
Psychosocial Deprivation | 462 | ||
Chronic Systemic Illnesses | 462 | ||
Hypothyroidism | 462 | ||
Evaluation and Management | 462 | ||
Measurement Techniques and Growth Charts | 463 | ||
Specific Elements of the Physical Examination | 463 | ||
Bone Age | 463 | ||
Diagnosis of Growth Hormone Deficiency | 463 | ||
Management | 464 | ||
Future Directions | 464 | ||
Suggested Readings | 464 | ||
XIII Disorders of the Nervous System | 465 | ||
74 Seizures | 466 | ||
Etiology and Pathogenesis | 466 | ||
Clinical Presentation | 466 | ||
Seizure Classification | 466 | ||
Febrile Seizures | 466 | ||
Epilepsy Syndromes | 466 | ||
Status Epilepticus | 467 | ||
Differential Diagnosis | 467 | ||
Evaluation | 468 | ||
Management | 468 | ||
Seizure First Aid | 468 | ||
Antiepileptic Medications | 469 | ||
Alternative Treatments | 469 | ||
Future Directions | 469 | ||
Suggested Readings | 470 | ||
75 Headache | 471 | ||
Etiology and Pathogenesis | 471 | ||
Clinical Presentation | 471 | ||
Evaluation and Management | 471 | ||
Treatment | 471 | ||
Abortive Medications | 471 | ||
Preventive Medications | 477 | ||
Nonpharmacologic Therapies | 477 | ||
Future Directions | 478 | ||
Suggested Readings | 478 | ||
76 Neurocutaneous Disorders | 479 | ||
Tuberous Sclerosis | 479 | ||
Von Hippel–Lindau Disease | 479 | ||
Neurofibromatosis Type 1 and 2 | 482 | ||
Sturge-Weber Syndrome | 483 | ||
Suggested Readings | 483 | ||
77 Cerebral Palsy | 485 | ||
Etiology and Pathogenesis | 485 | ||
Clinical Presentation | 485 | ||
Spastic Cerebral Palsy | 485 | ||
Dyskinetic Cerebral Palsy | 486 | ||
Ataxic Cerebral Palsy | 487 | ||
Differential Diagnosis | 487 | ||
Evaluation and Management | 487 | ||
Oromotor Dysfunction | 488 | ||
Spasticity | 488 | ||
Dyskinesias | 489 | ||
Alternative and Complementary Therapies | 489 | ||
Pain | 489 | ||
Prognosis | 489 | ||
Future Directions | 490 | ||
Suggested Readings | 490 | ||
78 Demyelinating Diseases | 491 | ||
Etiology and Pathogenesis | 491 | ||
Clinical Presentation and Differential Diagnosis | 491 | ||
Acute Disseminated Encephalomyelitis | 491 | ||
Clinically Isolated Syndrome | 491 | ||
Optic Neuritis | 491 | ||
Transverse Myelitis | 491 | ||
Multiple Sclerosis | 492 | ||
Neuromyelitis Optica | 493 | ||
Evaluation and Management | 493 | ||
Acute Therapy | 494 | ||
Special Considerations | 494 | ||
Multiple Sclerosis | 494 | ||
Neuromyelitis Optica | 494 | ||
Transverse Myelitis | 494 | ||
Future Directions | 494 | ||
Suggested Readings | 494 | ||
79 Stroke | 495 | ||
Etiology and Pathogenesis | 495 | ||
Clinical Presentation | 495 | ||
Differential Diagnosis | 497 | ||
Evaluation | 497 | ||
Management | 499 | ||
Special Considerations | 499 | ||
Perinatal Arterial Ischemic Stroke | 499 | ||
Sickle Cell Disease | 500 | ||
Focal Cerebral Arteriopathy of Childhood | 500 | ||
Moyamoya Disease and Syndrome | 501 | ||
Arterial Dissection | 501 | ||
Vasculitis | 501 | ||
Metabolic Stroke | 501 | ||
Conclusions and Future Directions | 501 | ||
Suggested Readings | 501 | ||
80 Spinal Cord Disorders | 503 | ||
Etiology and Pathogenesis | 503 | ||
Clinical Presentation and Differential Diagnosis | 503 | ||
Evaluation and Management | 504 | ||
Future Directions | 506 | ||
Suggested Readings | 507 | ||
81 Neuromuscular Disorders | 508 | ||
Anterior Horn Cell | 508 | ||
Spinal Muscular Atrophy | 508 | ||
Etiology and Pathogenesis | 508 | ||
Clinical Presentation | 508 | ||
Evaluation and Management | 508 | ||
Future Directions | 508 | ||
Peripheral Nerve | 510 | ||
Guillain-Barré Syndrome | 510 | ||
Etiology and Pathogenesis | 510 | ||
XIV Adolescent Medicine | 517 | ||
82 Substance Abuse | 518 | ||
Epidemiology and Pathogenesis | 518 | ||
Evaluation and Clinical Presentation | 518 | ||
Screening Adolescents for Substance Use | 518 | ||
Physical Examination Finding Related to Substance Use | 520 | ||
Management | 520 | ||
Future Directions | 521 | ||
Suggested Readings | 521 | ||
83 Menstrual Disorders | 522 | ||
Eitology and Pathogenesis | 522 | ||
Clinical Presentation | 522 | ||
Differential Diagnosis | 524 | ||
Treatment | 524 | ||
Conclusion | 524 | ||
Suggested Readings | 525 | ||
84 Polycystic Ovarian Syndrome | 526 | ||
Etiology and Pathogenesis | 526 | ||
Clinical Presentation | 526 | ||
Differential Diagnosis | 526 | ||
Screening and Evaluation | 526 | ||
Management | 527 | ||
Conclusion | 527 | ||
Suggested Readings | 527 | ||
85 Eating Disorders | 528 | ||
Etiology and Pathogenesis | 528 | ||
Clinical Presentation | 528 | ||
Differential Diagnosis | 528 | ||
Management | 528 | ||
Prognosis | 529 | ||
Conclusion | 529 | ||
Suggested Readings | 530 | ||
XV Infectious Disease | 531 | ||
86 Fever of Unknown Origin | 532 | ||
Differential Diagnosis | 532 | ||
Infection | 532 | ||
Bacterial Infections | 532 | ||
Viral Infections | 532 | ||
Other Infections | 532 | ||
Collagen Vascular and Autoimmune Disorders | 533 | ||
Malignancy | 534 | ||
Miscellaneous | 534 | ||
Approach to the Patient | 534 | ||
History | 534 | ||
Physical Examination | 534 | ||
Diagnostic Testing | 535 | ||
Screening Evaluation | 535 | ||
Laboratory Testing | 535 | ||
Diagnostic Imaging | 536 | ||
Invasive Testing | 537 | ||
Conclusion | 537 | ||
Suggested Readings | 537 | ||
87 Infections of the Head and Neck | 538 | ||
Cervical Lymphadenitis | 538 | ||
Etiology and Pathogenesis | 538 | ||
Clinical Presentation and Differential Diagnosis | 538 | ||
Evaluation and Management | 540 | ||
Deep Neck Infections | 541 | ||
Etiology and Pathogenesis | 541 | ||
Clinical Presentation and Differential Diagnosis | 542 | ||
Evaluation and Management | 543 | ||
Periorbital and Orbital Cellulitis | 543 | ||
Etiology and Pathogenesis | 543 | ||
Clinical Presentation and Differential Diagnosis | 544 | ||
Evaluation and Management | 545 | ||
Future Directions | 545 | ||
Suggested Readings | 545 | ||
Cervical Lymphadenitis | 545 | ||
Deep Neck Infections | 545 | ||
Periorbital and Orbital Cellulitis | 546 | ||
88 Osteomyelitis and Other Bone and Joint Infections | 547 | ||
Osteomyelitis | 547 | ||
Etiology | 547 | ||
Pathogenesis | 547 | ||
Clinical Presentation | 547 | ||
Diagnosis | 548 | ||
Treatment and Prognosis | 549 | ||
Septic Arthritis | 549 | ||
Etiology | 549 | ||
Pathogenesis | 550 | ||
Clinical Presentation | 550 | ||
Diagnosis | 550 | ||
Treatment and Prognosis | 551 | ||
Diskitis | 552 | ||
Suggested Readings | 552 | ||
89 Sexually Transmitted Infections | 553 | ||
Vaginitis | 553 | ||
Urethritis and Cervicitis | 553 | ||
Epidemiology and Pathophysiology | 553 | ||
Clinical Presentation | 553 | ||
Pelvic Inflammatory Disease | 553 | ||
Other Manifestations of Gonococcal and Chlamydial Infection | 553 | ||
Evaluation and Management | 556 | ||
Anogenital Lesions | 556 | ||
Syphilis | 556 | ||
Diagnosis | 556 | ||
Treatment | 558 | ||
Herpes Genitalis | 558 | ||
Epidemiology and Pathophysiology | 558 | ||
Clinical Presentation | 558 | ||
Diagnosis and Management | 558 | ||
Human Papillomavirus | 559 | ||
Epidemiology and Pathophysiology | 559 | ||
Clinical Presentation | 559 | ||
Diagnosis and Management | 560 | ||
Conclusion | 560 | ||
Suggested Readings | 561 | ||
90 Skin and Soft Tissue Infections | 562 | ||
Etiology and Pathogenesis | 562 | ||
Organisms | 562 | ||
Clinical Presentation | 562 | ||
Folliculitis | 562 | ||
Furuncles and Carbuncles | 562 | ||
Impetigo | 563 | ||
Erysipelas | 563 | ||
Cellulitis | 563 | ||
Necrotizing Fasciitis | 565 | ||
Evaluation and Management | 566 | ||
Mild Infections | 566 | ||
Moderate Infections | 566 | ||
Severe Infections | 567 | ||
Antimicrobials | 567 | ||
Suggested Readings | 567 | ||
91 Pneumonia and Respiratory Infections | 568 | ||
Etiology and Pathogenesis | 568 | ||
Epidemiology | 568 | ||
Microbiology | 568 | ||
Pathogenesis | 568 | ||
Clinical Presentation and Differential Diagnosis | 570 | ||
Evaluation and Management | 571 | ||
Diagnostic Methods | 571 | ||
Treatment | 573 | ||
Future Directions | 574 | ||
Suggested Readings | 574 | ||
92 Infections of the Central Nervous System | 575 | ||
Meningitis and Meningoencephalitis | 575 | ||
Etiology, Epidemiology, and Pathogenesis | 575 | ||
Clinical Presentation | 575 | ||
Differential Diagnosis | 575 | ||
Diagnostic Approach | 576 | ||
Management and Therapy | 577 | ||
Focal Suppurative Infections: Brain Abscess | 578 | ||
Etiology, Epidemiology, and Pathogenesis | 578 | ||
Clinical Presentation | 578 | ||
Diagnostic Approach | 579 | ||
Management and Therapy | 579 | ||
Subdural Empyema | 580 | ||
XVI Neonatal Medicine | 633 | ||
100 Hyperbilirubinemia | 634 | ||
Etiology and Pathogenesis | 634 | ||
Clinical Presentation | 634 | ||
Unconjugated Hyperbilirubinemia | 634 | ||
Conjugated Hyperbilirubinemia | 635 | ||
Evaluation and Management | 635 | ||
Unconjugated Hyperbilirubinemia | 635 | ||
Conjugated Hyperbilirubinemia | 636 | ||
Future Directions | 637 | ||
Suggested Readings | 639 | ||
101 Disorders of the Nervous System | 640 | ||
Etiology and Pathogenesis | 640 | ||
XVII Disorders of the Digestive System | 675 | ||
107 Disorders of the Esophagus | 676 | ||
Developmental Anomalies | 676 | ||
XVIII Genetic and Metabolic Disorders | 731 | ||
116 Principles of Human Genetics | 732 | ||
Chromosome Structure and Nomenclature | 732 | ||
Methods Of Detecting Aneuploidy | 732 | ||
Mitosis, Meiosis, and Gamete Formation | 732 | ||
Gene Structure | 734 | ||
Modes of Inheritance | 734 | ||
Autosomal Dominant Inheritance | 735 | ||
Autosomal Recessive Inheritance | 735 | ||
Sex-Linked Inheritance | 736 | ||
Mitochondrial Inheritance | 736 | ||
Uniparental Disomy | 736 | ||
Mosaicism | 736 | ||
Polygenic-Multifactorial Inheritance | 736 | ||
Evaluation and Diagnosis of Genetic Syndromes | 736 | ||
Categories of Dysmorphic Disorders | 736 | ||
Evaluation of Children with Dysmorphism | 737 | ||
Future Directions | 737 | ||
Suggested Readings | 739 | ||
117 Trisomy 21 | 740 | ||
Etiology and Pathogenesis | 740 | ||
Clinical Presentation and Differential Diagnois | 740 | ||
Phenotypic Features | 740 | ||
Developmental Impairment | 740 | ||
Comorbidities | 741 | ||
Heart Disease | 741 | ||
Gastrointestinal Disease | 742 | ||
Growth and Stature | 742 | ||
Obesity | 742 | ||
Disturbances of Vision | 742 | ||
Disturbances of Hearing | 742 | ||
Hematologic Disorders | 742 | ||
Oncologic Disorders | 742 | ||
Transient Leukemia | 742 | ||
Acute Megakaryoblastic Leukemia | 743 | ||
Acute Lymphoblastic Leukemia | 743 | ||
Immune Deficiency | 743 | ||
Endocrinologic Disorders | 743 | ||
Reproductive Concerns | 743 | ||
Atlantoaxial Instability | 743 | ||
Sleep Apnea | 743 | ||
Skin Disorders | 743 | ||
Behavior Disturbances | 744 | ||
Recent Advances and Future Directions | 744 | ||
Learning and Memory | 744 | ||
Alzheimer Disease | 744 | ||
Cancer | 744 | ||
Cognitive Ability | 744 | ||
Suggested Readings | 744 | ||
118 Chromosomal Abnormalities | 745 | ||
Trisomy 18 (Edwards Syndrome) | 745 | ||
XIX Dermatologic Disorders | 781 | ||
122 Dermatologic Morphology | 782 | ||
Basic Structure Of The Skin | 782 | ||
Epidermis | 782 | ||
Dermis | 782 | ||
Subcutaneous Tissue | 782 | ||
Approach To Dermatologic Morphology And Disease | 782 | ||
Primary Lesions | 782 | ||
Secondary Lesions | 782 | ||
Color of Lesions | 783 | ||
Configuration of Lesions | 783 | ||
Distribution of Lesions | 786 | ||
Suggested Readings | 786 | ||
123 Vascular Disorders | 787 | ||
Vascular Tumors | 787 | ||
Infantile Hemangiomas | 787 | ||
Etiology and Pathogenesis | 787 | ||
Clinical Manifestations | 787 | ||
Management | 787 | ||
Congenital Hemangiomas | 787 | ||
PHACES Syndrome | 788 | ||
Tufted Angiomas | 788 | ||
Kaposiform Hemangioendothelioma | 788 | ||
Kasabach-Merritt Phenomenon | 789 | ||
Pyogenic Granuloma | 789 | ||
Vascular Malformations: Slow-Flow Lesions | 789 | ||
Capillary Malformations | 789 | ||
Nevus Flammeus | 789 | ||
Sturge-Weber Syndrome | 789 | ||
Nevus Simplex | 789 | ||
Telangiectasias | 790 | ||
Angiokeratoma | 790 | ||
Venous Malformations | 790 | ||
Glomuvenous Malformations | 790 | ||
Lymphatic Malformations | 790 | ||
VaScular Malformations: Fast-Flow Lesions | 790 | ||
Arteriovenous Malformations | 790 | ||
Suggested Readings | 791 | ||
124 Hyperpigmented Skin Disorders | 792 | ||
Etiology And Pathogenesis | 792 | ||
Circumscribed Hyperpigmented Skin Lesions | 792 | ||
Freckles (Ephelides) | 792 | ||
Lentigines | 792 | ||
Café-au-Lait Spots | 792 | ||
Mastocytosis | 793 | ||
Acanthosis Nigricans | 795 | ||
Dermal Melanosis | 795 | ||
Postinflammatory Hyperpigmentation | 795 | ||
Linear Circumscribed Hyperpigmented Lesions | 796 | ||
Incontinentia Pigmenti | 796 | ||
Diffuse Hyperpigmentation | 796 | ||
Suggested Readings | 796 | ||
125 Acne | 798 | ||
Etiology And Pathogenesis | 798 | ||
Clinical Presentation | 798 | ||
Management | 798 | ||
Topical Retinoids | 799 | ||
Topical Benzoyl Peroxide | 799 | ||
Topical Antibiotics and Combination Products | 799 | ||
Systemic Antibiotics and Other Systemic Therapies | 801 | ||
Future Directions | 802 | ||
Suggested Readings | 802 | ||
126 Nevi | 803 | ||
Etiology And Pathogenesis | 803 | ||
Clinical Manifestation And Management | 803 | ||
Common Acquired Melanocytic Nevi | 803 | ||
Dysplastic or Atypical Nevi | 803 | ||
Congenital Nevi | 803 | ||
Special Nevi | 805 | ||
Nevus Spilus or Speckled Lentiginous Nevus | 805 | ||
Blue Nevus | 805 | ||
Spitz Nevi | 805 | ||
Halo Nevi | 805 | ||
Suggested Readings | 806 | ||
127 Nutritional Dermatoses | 807 | ||
Etiology And Pathogenesis | 807 | ||
Clinical Presentation | 807 | ||
Protein-Energy Malnutrition | 807 | ||
Zinc Deficiency | 807 | ||
Essential Fatty Acid Deficiency | 808 | ||
Biotin Deficiency | 808 | ||
Niacin Deficiency | 808 | ||
Other Vitamin B Complex Deficiencies | 809 | ||
Vitamin C Deficiency | 810 | ||
Evaluation And Management | 810 | ||
Future Directions | 811 | ||
Suggested Readings | 811 | ||
Index | 813 | ||
A | 813 | ||
B | 815 | ||
C | 816 | ||
D | 818 | ||
E | 819 | ||
F | 820 | ||
G | 821 | ||
H | 822 | ||
I | 823 | ||
J | 825 | ||
K | 825 | ||
L | 825 | ||
M | 826 | ||
N | 827 | ||
O | 828 | ||
P | 828 | ||
Q | 830 | ||
R | 830 | ||
S | 831 | ||
T | 833 | ||
U | 834 | ||
V | 834 | ||
W | 835 | ||
X | 835 | ||
Z | 835 |